Skip to main content
HYUNDAI PHARMACEUTICAL CO., LTD logo

HYUNDAI PHARMACEUTICAL CO., LTD — Investor Relations & Filings

Ticker · 004310 ISIN · KR7004310009 KO Manufacturing
Open in API
Filings indexed 184 across all filing types
Latest filing 2023-12-26 Earnings Release
Country KR South Korea
Listing KO 004310

About HYUNDAI PHARMACEUTICAL CO., LTD

http://www.hyundaipharm.co.kr/english

HYUNDAI PHARMACEUTICAL CO., LTD. is a company engaged in the research, development, manufacturing, and distribution of pharmaceutical products, medical devices, and health-focused food and beverages. The company's portfolio encompasses a broad range of prescription (ETC) and over-the-counter (OTC) medicines. Key therapeutic areas include dermatology, respiratory and gastrointestinal disorders, as well as treatments for conditions such as hypertension and dementia. With a strong commitment to innovation, the company focuses on the research of new substances and the continuous development of its drug pipeline. It also serves as a strategic partner for global companies, facilitating market entry and collaboration through its business development initiatives.

Recent filings

Filing Released Lang Actions
매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release Classification · 100% confidence The document is a regulatory filing from Hyundai Pharm regarding a significant change in sales or profit structure (30% or more). It provides preliminary financial results (revenue, operating profit, net income) for the fiscal year compared to the previous year. This type of disclosure is a standard regulatory requirement for listed companies in Korea to announce material changes in financial performance before the final audit report is filed. It fits the definition of an Earnings Release (ER) as it provides key financial highlights and performance metrics. FY 2023
2023-12-26 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '임시주주총회 결과' (Extraordinary General Meeting Results) and details the outcome of voting items (resolutions) from a shareholder meeting held on 2023-11-22. Since it reports the official results of shareholder votes, it falls under the Declaration of Voting Results category.
2023-11-22 Korean
[첨부추가]주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of an Extraordinary General Meeting (임시주주총회) for Hyundai Pharm. It details the date, location, and agenda items (such as amendments to the articles of incorporation). This type of document is a standard proxy solicitation or notice of meeting, which falls under the Proxy Solicitation & Information Statement category.
2023-11-06 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of Extraordinary General Meeting of Shareholders' (주주총회소집공고) issued by Hyundai Pharm Co., Ltd. It details the meeting date, location, agenda items (such as amendments to the articles of incorporation), and instructions for electronic voting. This type of document is designed to provide shareholders with the necessary information to vote on corporate matters, which falls under the category of Proxy Solicitation & Information Statement.
2023-11-06 Korean
분기보고서 (2023.08)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Hyundai Pharmaceutical Co., Ltd. (현대약품(주)) covering the period from December 1, 2022, to August 31, 2023. It contains detailed financial information, business operations, management discussions, and corporate governance data, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2023
2023-10-16 Korean
신탁계약에의한취득상황보고서
Transaction in Own Shares Classification · 100% confidence The document is a 'Report on Acquisition Status via Trust Agreement' (신탁계약등에의한취득상황보고서) filed by Hyundai Pharm Co., Ltd. to the Financial Supervisory Service (FSS). It details the company's share buyback activities conducted through a trust agreement with Samsung Securities. This type of filing specifically reports the company's transactions in its own shares, which falls under the 'Transaction in Own Shares' category.
2023-10-16 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.